Press Releases

Additional capital strengthens the Company’s financial profile and enables management to execute against strategic growth objectives.

Covetrus released select preliminary first quarter ended March 31, 2020 financial results and provided an update on its operations

Covetrus is embedding secure video teleconferencing capabilities across the company’s global suite of PIMS, client communications and prescription management solutions.

Covetrus announced that it has completed the sale of its scil animal care business to Heska Corporation.

The Covetrus network of pharmacies has seen a significant increase in the number of prescriptions for medications and therapeutic diet food to be filled and shipped to pet owners on behalf of their veterinarians.

We at Covetrus continue to closely monitor the coronavirus and its impact across the globe with a focus on the health and safety of our employees, customers and supply chain partners.

David E. Shaw has informed the company that he will not stand for re-election at the company’s annual meeting of stockholders to be held in May 2020. The company has also announced that the board has nominated Sharon Wienbar for election to the Covetrus board of directors at the annual meeting of stockholders.

Covetrus shares the world’s concern about the outbreak of COVID-19. Our first priority is the health and safety of our employees, supply chain partners and customers.

Covetrus announced that Benjamin Wolin will become the company’s president and chief executive officer in conjunction with the company’s fourth quarter and full year 2019 financial results.

Covetrus will release fourth quarter and full year 2019 results after the market close on Tuesday, March 3, 2020.